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Empirical comparison of reduced representation bisulfite
sequencing and Infinium BeadChip reproducibility and
coverage of DNA methylation in humans
Juan J. Carmona1,2,3, William P. Accomando Jr.4,5, Alexandra M. Binder4,5, John N. Hutchinson6, Lorena Pantano6, Benedetta Izzi7,
Allan C. Just1, Xihong Lin6, Joel Schwartz1, Pantel S. Vokonas8, Sami S. Amr 9,10, Andrea A. Baccarelli1,4 and Karin B. Michels4,5
We empirically examined the strengths and weaknesses of two human genome-wide DNA methylation platforms: rapid
multiplexed reduced representation bisulfite sequencing and Illumina’s Infinium BeadChip. Rapid multiplexed reduced
representation bisulfite sequencing required less input DNA, offered more flexibility in coverage, and interrogated more CpG loci at
a higher regional density. The Infinium covered slightly more protein coding, cancer-associated and mitochondrial-related genes,
both platforms covered all known imprinting clusters, and rapid multiplexed reduced representation bisulfite sequencing covered
more microRNA genes than the HumanMethylation450, but fewer than the MethylationEPIC. Rapid multiplexed reduced
representation bisulfite sequencing did not always interrogate exactly the same CpG loci, but genomic tiling improved overlap
between different libraries. Reproducibility of rapid multiplexed reduced representation bisulfite sequencing and concordance
between the platforms increased with CpG density. Only rapid multiplexed reduced representation bisulfite sequencing could
genotype samples and measure allele-specific methylation, and we confirmed that Infinium measurements are influenced by
nearby single-nucleotide polymorphisms. The respective strengths and weaknesses of these two genome-wide DNA methylation
platforms need to be considered when conducting human epigenetic studies.
npj Genomic Medicine  (2017) 2:13 ; doi:10.1038/s41525-017-0012-9
INTRODUCTION
Epigenetics is the study of mitotically and/or meiotically heritable
gene regulation that is not due to changes in the primary
sequence of DNA nucleotides.1 DNA methylation (DNAm) at
cytosine residues in cytosine-guanine (CpG) dinucleotides is one
of the most studied epigenetic marks; it is relatively easy to
measure, critical to the maintenance of cellular identity,2, 3 and
related to chromatin conformation and transcriptional program-
ming.3–6 CpG loci are statistically underrepresented in mammalian
genomes, but they are often concentrated in regions known as
CpG “islands”, and ~60% of known human gene promoters
contain CpG islands.7 Genomic regions 2000 base-pairs (2 kb) to
each side of a CpG island are CpG “shores,” with CpG “shelves”
extending 2 kb beyond CpG shores, with the rest of the genome
termed “open sea”. These four contexts form the CpG “resort”, and
the concentration of CpG loci decreases from islands to the open
sea.8 The context of interest may depend on the research
question. For example, since DNAm within promoter CpG islands
exhibits patterns established during cellular differentiation and
passed down through cell lineages,9 scientists investigating cell-
lineage-specific gene regulation and/or identifying epigenetic
biomarkers of cell and tissue types may focus on promoter CpG
islands.10–13 On the other hand, since DNAm in CpG shores and
shelves is more responsive to external factors,14–16 scientists
investigating environmental programming of the genome via
DNAm and/or trying to determine whether DNAm mediates
known associations between exposures and diseases may focus
on CpG shores and shelves.
Approaches that measure DNAm are continually being devel-
oped and refined. Many probe- and sequencing-based DNAm
quantification approaches take advantage of sodium bisulfite
treatment, which converts unmethylated cytosines to uracil
(becoming thymine after PCR amplification) without changing
methylated cytosines, allowing quantification of DNAm via
estimation of cytosine-to-thymine at known CpG loci.17 Probe-
based detection employs site-specific probes that hybridize onto
bisulfite-converted DNA at target CpG loci, resulting in fluorescent
signals. Infinium BeadChip arrays from Illumina (San Diego, CA),
including the HumanMethyation450 (450K), and MethylationEPIC
(850K), measure DNAm at pre-defined CpG loci with a generally
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high level of reproducibility and reliability,8, 18–20 but share some
limitations. The required input DNA of 500 ng–1 µg precludes the
use of Infinium arrays for scarce/precious samples, such as micro-
dissected cancer biopsies. The invariable (and limited) set of CpG
loci on Infinium arrays were designed to capture RefSeq genes
and promoter CpG islands, excluding other regions of biologically
meaningful variation. Customizable DNAm array options, such as
Illumina’s VeraCode GoldenGate Methylation Assay use older
technology21 and only examine a small number of CpG loci (384
loci per array), which are restricted by probe chemistry. Newer
Infinium arrays also have issues with dye-biases, different probe
chemistries and positional effects that are known to influence
results and must be corrected during data processing.22–24
Infinium 450K probe cross-reactivity and ambiguous mapping to
multiple locations in the human genome affects ~140,000 out of
485,000 probes (29% of the array), potentially reducing the
number of usable probes to ~345,000,25, 26 an issue that persists
with the newly released 850K, which includes >90% of the 450K
probes.
Sequencing-based approaches for measuring DNAm across the
human genome have rapidly evolved over the last decade. Whole-
genome bisulfite sequencing (WGBS) requires a very large amount
of DNA, often 3 μg, to generate a large amount of data that is
expensive to store, much of which is not useful due to a lack of
variability and/or overlap between samples.27–29 To overcome
these limitations, reduced representation bisulfite sequencing
(RRBS) was developed, requiring less DNA (10–200 ng) and able to
generate more meaningful data than WGBS.30 A modified form of
generalized RRBS, multiplexed RRBS (mRRBS) improved feasibility
for large studies by allowing multiple libraries per sequencing
lane,29 and others have further modified mRRBS for particular
applications.31, 32 We refined mRRBS to allow for faster and more
efficient throughput, thus creating a “rapid multiplexed” RRBS
(rmRRBS) platform for the quantification of genome-wide DNAm.
Briefly, genomic DNA (gDNA) is digested with MspI restriction
enzyme, which targets CpG-rich areas, to generate a library of
fragments that each contains at least two CpG loci. After ligating
indexed oligonucleotide adapters to these fragments and
performing size selection using magnetic beads, rmRRBS libraries
are pooled, treated with sodium bisulfite, PCR amplified, cleaned
up, and then subjected to next-generation sequencing (NGS). The
sequenced reads are then aligned to a reference genome and
stacked to yield “read depth,” i.e., the number of reads per region
(e.g., 1×, 2×, etc.). Unlike probe-based approaches, sequencing-
based approaches like rmRRBS are able to measure single-
nucleotide polymorphisms (SNPs) and quantify allele specific
DNAm (ASM).33–35 SNPs can impact DNAm estimates by altering
the primary sequence of nucleotides to eliminate (or add) a CpG
locus, and by influencing DNAm at nearby CpG loci.36 ASM is of
particular interest to studies of human imprinting, a phenomenon
where one parental allele is expressed in a parent-of-origin-
specific manner, while the other is silenced. For example, the
11p15 chromosomal region contains a contiguous multigene
imprinting cluster including H19, a long non-coding RNA gene
that is only expressed by the hypomethylated maternal allele,
while the hypermethylated paternal allele is silenced.37 Loss of
imprinting in 11p15 is associated with childhood growth disorders
and cancer, such as Beckwith–Wiedemann syndrome and Wilms
tumor,38 as well as adult cancers.39
This work is an in-depth examination of rmRRBS genomic
coverage and precision for a range of human DNA input
quantities. We also explore analytic approaches to RRBS data,
including genomic tiling, SNP detection, and ASM quantification.
Our goal is to inform researchers who are considering probe-
based and/or sequencing-based genome-wide DNAm platforms
for epigenetic investigations from basic science to epidemiologic
studies.
RESULTS
Genomic coverage
We constructed and sequenced 86 rmRRBS libraries using human
peripheral blood gDNA obtained from 10 adult males, labeled A–J
(Supplementary Table S1), which we also evaluated via the
Infinium 450K. We performed RRBS in silico to indicate expected
RRBS coverage, and used Illumina’s manifest files to determine
expected 450K and 850K coverage. We first selected 12 of the
rmRRBS libraries—including two technical replicates—to examine
in detail. Reflecting the rmRRBS enrichment protocol, genomic
coverage varied by genetic element (Figs. 1 and 2; Supplementary
Table S2). The number of reads at specific CpG loci for each of the
12 libraries can be viewed in the University of California Santa Cruz
Genome Browser (see Supplemental Materials). Stratifying by CpG
resort context, all 12 rmRRBS libraries covered from hundreds to
over a million more CpG loci than the Infinium arrays at ≥4×, and
five to ten libraries covered from hundreds to over a million more
CpG loci than the Infinium arrays at ≥10× (Fig. 1a). This trend was
recapitulated when we stratified by four categories of human
genes: protein-coding genes, cancer-associated genes, nuclear-
encoded genes related to mitochondrial function, and microRNA
(miRNA) genes (Fig. 2a). With the exception of CpG islands and
miRNA genes, our rmRRBS libraries did not perform as well as
predicted by performing RRBS in silico.
Five libraries covered a greater diversity of discrete CpG shores
than the 450K at ≥4×, eleven libraries covered more open sea
regions than the 450K at ≥10×, but none covered as many CpG
islands and shelves as the 450K, and the 850K covers at least as
many of all four contexts as the rmRRBS libraries (Fig. 1b). At ≥4×,
a majority of the rmRRBS libraries measured at least one CpG locus
in ~75% and ~65% of the exact same CpG islands and shores,
respectively, captured on the Infinium arrays, but only about a
third of the exact same CpG shelves (Fig. 1c–d). Even at ≥10×, nine
rmRRBS libraries covered a larger number of microRNA genes than
the 450K and a comparable absolute number of cancer-associated
genes, protein-coding genes, and nuclear-encoded genes with
mitochondrial function to both the 450K and 850K (Fig. 2b).
Moreover, overlap between the rmRRBS libraries at ≥10× and the
Infinium arrays ranged from 83% to 93% for protein-coding genes,
93–98% for cancer-associated genes, 80–96% for mitochondrial-
Fig. 1 Genomic coverage of 12 rmRRBS libraries at different read depths stratified by CpG resort context. a The total number of CpG loci
covered, b the number of discrete contexts in which at least one CpG locus is covered, c the proportion of exactly the same contexts from the
Infinium HumanMethyaltion450 (450K) array for which at least once CpG locus was covered, and d the proportion of exactly the same
contexts from the Infinium MethyaltionEPIC (850K) array for which at least once CpG locus is covered are plotted from ≥1× to ≥10× reads. In
panels (a)–(d), the dark red horizontal lines indicate predicted RRBS genomic coverage, bioinformatically determined by performing RRBS in
silico. In panels (a) and (b), the dark green horizontal lines indicate Infinium 450K genomic coverage, and the dark blue horizontal lines
indicate Infinium 850K genomic coverage. (e) The distribution of the number of CpG loci measured in each discrete region that was covered is
stratified in columns by type of CpG context and in rows by rmRRBS read depth, with CpG density distributions for in silico RRBS, the Infinium
450K, and the Infinium 850K plotted together in the fourth row. The peak of the density is the mode, and indicates most common number of
CpG loci measured in each region. In all panels, unique individuals A through J appear as different colored lines where solid lines indicate
normal cluster density and dotted lines indicated high cluster density
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related genes, and 30–68% for microRNA genes (Fig. 2c–d).
Regardless of genomic context, rmRRBS covered more CpG loci
per region than the Infinium arrays (Figs. 1e, 2e). Likewise, rmRRBS
measured a higher density of CpG loci in all 30 known human
imprinting regions—which were covered at ≥10× by all 12
libraries—than the Infinium arrays (data not shown).
We next investigated overlap in genomic coverage between
rmRRBS libraries, which is dependent on both read depth and the
minimum number of libraries that must capture the same CpG
locus. In addition to looking at individual CpG loci, we also divided
the human genome into discrete genomic “tiles” that never span
more than one type of CpG resort context. As expected, the
correlation between DNAm at CpG loci decreased as the distance
between the loci increased. However, the rate at which this
correlation dissipated was dependent on the CpG resort context.
DNAm in CpG islands was highly correlated across much larger
regions than other resort contexts (Supplementary Fig. S1). To
appraise the impact of this variability across regions on
reproducibility, we created two sets of genomic tiles to increase
overlap across libraries: one set with a maximum size of 200 base-
pairs (200 bp) and another set with a maximum size of 2000 base-
pairs (2 kb), the previously defined size of a CpG shore or shelf
region. All 12 libraries at ≥4× read depth, and up to 10 libraries at
≥10×, overlapped at more individual CpG loci (>482,421), 200 bp
tiles (>354,806) and 2 kb tiles (>225,403) than are captured by the
450K (Fig. 3). Furthermore, we found that different rmRRBS
libraries covered a large number of exactly the same protein-
coding, cancer-associated, microRNA and mitochondrial-related
genes. The best overlap in coverage among the types of genes
considered was in microRNAs. In fact, all 12 rmRRBS libraries at
≥4×, and up to 10 libraries at ≥10×, overlapped at >715 microRNA
genes—more than the 599 microRNA genes present on the 450K.
Figure 3 also displays putative 850K coverage, which is particularly
improved over the 450K for 200 bp tiles, 2 kb tiles and microRNA
genes. The number of cancer-associated and mitochondrial-
related genes that overlapped between rmRRBS libraries were≥
95% and ≥90%, respectively, of the number on the Infinium
arrays.
DNAm quantification
In order to test the precision of rmRRBS DNAm measurements,
and to determine the influence of experimental variables, we
prepared 72 technical replicates from one individual’s gDNA
sample—12 libraries each under six different conditions, including
two laboratory protocols (NEBNext and rmRRBS) with 60, 100, and
200 ng of starting gDNA input (Supplementary Table S3). At 10x
coverage and with 200 ng of starting gDNA, the rmRRBS protocol
Fig. 2 Genomic coverage of 12 rmRRBS libraries at different read depths stratified by four types of genes. a The total number of CpG loci
covered b the number of genes in which at least one CpG locus is covered c the proportion of genes on the Infinium HumanMethyation450
(450K) array for which at least once CpG locus is covered, and d the proportion of genes on the Infinium MethyationEPIC (850K) array for
which at least once CpG locus is covered are plotted from ≥1× to ≥10× reads. In panels (a)–(d), the dark red horizontal lines indicate predicted
RRBS genomic coverage, bioinformatically determined by performing RRBS in silico. In panels (a) and (b), the dark green horizontal lines
indicate Infinium 450K genomic coverage, and the dark blue horizontal lines indicate Infinium 850K genomic coverage. (e) The distribution of
the number of loci measured in each gene that was covered is stratified in columns by type of gene and in rows by mRRBS read depth, with
CpG density distributions for in silico RRBS, the Infinium 450K and the Infinium 850K plotted together in the fourth row. The peak of the
density is the mode, and indicates most common number of CpG loci measured in each gene. In all panels, unique individuals A through J
appear as different colored lines where solid lines indicate normal cluster density and dotted lines indicated high cluster density
Fig. 3 Overlap in genomic coverage between different rmRRBS libraries. The number of CpG loci, CpG resort context-restricted genomic tiles
up to 200 base pairs (200 bp tiles) or 2000 base pairs (2 kb tiles) in length, protein coding genes, cancer-associated genes, microRNA genes,
and nuclear encoded genes related to mitochondrial function are plotted relative to the number of rmRRBS libraries in which exact matches
overlap. Different color lines correspond rmRRBS read depth, ranging from ≥1× to ≥10× reads per CpG locus, 200 bp, 2 kb tile, or gene. For
reference, horizontal lines indicate the number of CpG loci, tiles or genes covered by the Infinium HumanMethylation450 (450K; dark green)
and the Infinium MethyationEPIC (850K; dark blue)
Comparison of RRBS and Infinium DNA methylation
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captured a greater number of CpG loci on average, specifically
among CpG islands, shores, and shelves on average. However, the
NEBNext protocol tended to capture more open sea sites
(Supplementary Table S4). For each CpG locus, 200 bp tile or 2
kb tile, we combined all sequencing reads for each condition to
serve as standards. Stratifying by CpG context, we calculated the
correlation of DNAm between each library and its standard,
revealing that the reproducibility of rmRRBS DNAm measurements
increased with read depth and CpG density (Fig. 4). At ≥10x reads,
R-values between libraries and their standards were >0.9 for
islands and shores and >0.85 for shelves and open sea. Within CpG
islands, reproducibility further improved when 200 bp and 2 kb
tiles were employed. Outside of CpG islands, using 200 bp tiles
had little effect, whereas using 2 kb tiles reduced reproducibility,
particularly in shelves and open sea regions. Comparing DNAm
measurements via rmRRBS to averaged triplicate Infinium
measurements for the same gDNA sample, concordance between
rmRRBS and Infinium DNAm measurements increased with both
CpG density and rmRRBS read depth (Fig. 5). The Pearson
correlation between rmRRBS estimated percent methylation and
450K methylation level for all overlapping loci at ≥1x and ≥10x
can be viewed in Genome Browser (Supplemental Materials). For
ten libraries at ≥10x reads, correlations with Infinium DNAm at
individual CpG loci were >0.95, >0.93, >0.85, and >0.88 for islands,
shores, shelves, and open sea, respectively. Using 200 bp tiles
rather than matching individual CpG loci increased the correlation
between platforms, regardless of CpG context. Although using 2
kb tiles increased the correlation between platforms for DNAm
measured in CpG islands even more than using 200 bp tiles, it
decreased the correlation between platforms outside of CpG
islands.
To assess the ability for rmRRBS to detect SNPs and measure
ASM, we plotted ASM within the imprinting control region of H19
in proximity to a common G/T SNP (rs10840167) for which seven
rmRRBS libraries were heterozygous with ≥4x reads per allele.
Epigenomic Roadmap data for the region with the SNP predicts
leukocyte regulatory functions, including enhancer activity for
lymphoid immune cells and repressed polycomb activity for
myeloid immune cells.40 Across the five CpG loci captured on the
same read as the SNP, we found that one allele was fully
methylated and the other was fully unmethylated, suggesting that
these loci exhibit parental imprinting (Fig. 6). Since the Infinium
array cannot measure ASM, the expected methylation value for
these loci is 50% (the average of DNAm from the two alleles).
Instead the two samples that showed higher methylation on the
T-allele had high (~89%) methylation at the locus that overlapped
with this region on the Infinium 450K, whereas the methylation
level ranged from 35 to 48% for the rest of the samples.
DISCUSSION
We empirically assessed a derivative of RRBS optimized for high-
throughput, called rmRRBS, and Infinium BeadChip technology.
Our work suggests that there are many trade-offs to consider
when selecting between array-based and/or sequencing-based
DNAm platforms for human research studies. Compared to the
Infinium array, NGS-based rmRRBS is capable of covering more
CpG loci and a greater abundance of CpG shores, which are
thought to be important for exposure-related epigenetic mod-
ifications, as well as open sea regions. Additionally, rmRRBS tends
to cover more CpG loci within a given region than the Infinium.
Unlike array-based approaches, however, the exact same CpG loci
are not always measured across rmRRBS libraries. Moreover, the
number of reads covering each site impacts quantitative
estimation of DNAm, thereby influencing reproducibility. All
rmRRBS libraries are generated by enzymatic digestion of the
genome, so there is no guarantee that a fragment will be
generated even if the correct restriction sites flank the area.
Furthermore, even if the digestion generates a particular
fragment, it must also be properly ligated onto adapters, bisulfite
converted, PCR amplified, sequenced, and successfully aligned in
order for a CpG locus therein to be analyzed as a discrete read.
Thus, there will usually be some experimental variation between
libraries, which manifests as differences in genomic coverage and
depth. This work considered variability due to DNA input quantity
for a commonly used biologic sample: human blood. Future work
should explore other potential sources of variability, particularly
those affecting DNA quality, such as different origins (e.g., tumor
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tissue, cell lines, cultured primary cells), storage conditions,
purities, and extraction methods. Since RRBS libraries are
generated by fractionating DNA early in the procedure, premature
fractionation is unlikely to significantly affect results. This suggests
that rmRRBS is a suitable platform for samples of uncertain or
poorer quality, such as DNA derived from formalin fixed paraffin
embedded tissue and clinical samples that were processed or
stored under sub-optimal conditions. However, additional sys-
tematic experiments are needed to assess rmRRBS performance
relative to array-based approaches for poorer quality DNA.
Considering DNAm across tiles, rather than individual CpG loci,
can improve overlap across rmRRBS libraries. While different
libraries may not cover precisely the same CpG loci, they may
cover CpG loci in close proximity. As anticipated, the impact of tile
size on rmRRBS reproducibility and concordance with Infinium
measurements depended on the variability of DNAm within the
genomic region. For less variable elements, such as CpG islands,
even relatively large tiles improved the precision of DNAm
estimates. In regions where the correlation between loci dropped
quickly with distance, such as shores and shelves, smaller tiles
were necessary. Our capacity to estimate these regional DNAm
patterns is facilitated by the greater density of CpG loci among
contexts covered compared to the Infinium.
Unlike Infinium BeadChip arrays, rmRRBS allows for both
genotyping (i.e., SNP detection) and the measurement of ASM,
making it a powerful platform for studies of imprinting and other
types of monoallelic DNAm. Our examination of the 11p15
imprinting region (specifically H19) not only revealed that rmRRBS
is effective at measuring ASM, but it also confirmed that Infinium
DNAm quantification can be confounded by the status of SNPs near
the target CpG, thus introducing bias that is usually avoided by
removing all known SNP proximal Infinium probes from analysis.
If sample material or DNA is scarce, it may not be possible to
use Infinium BeadChip arrays, which require 500 ng–1 μg of DNA
(or WGBS, which requires 3 μg of DNA). Herein, we demonstrate
that rmRRBS can measure genome-wide DNAm using 60–200 ng
of DNA. Both platforms require high-quality DNA input. There is a
possibility that rmRRBS may be more sensitive to microbial
contamination, such as might be found in saliva or buccal cell
DNA, than the Infinium array, but this remains to be tested. The
overall costs of running rmRRBS and the Infinium are comparable
considering requisite labor, reagents, and bioinformatics. If the
investigator has abundant DNA, Infinium arrays are likely the
better option due to their consistency in both genomic coverage
and DNAm estimates. There are some concerns involving dye-bias
between the different probe types, as well as positional and batch
effects on Infinium arrays, but these have been mostly resolved in
well-established bioinformatics pipelines.22, 24, 41, 42 On the other
hand, rmRRBS offers greater flexibility in the genomic regions that
are detected, with the potential to investigate DNAm at sites that
are not interrogated by Infinium arrays, which could lead to the
discovery of novel biomarkers that would be missed otherwise. In
our work, we found that a larger number (and a different pool) of
microRNA genes were covered by rmRRBS than the Infinium 450K.
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Fig. 5 Concordance of rmRRBS and Infinium DNA methylation measurements. The Pearson correlations between DNA methylation
measurements from 12 rmRRBS libraries derived from ten different participants’ (labeled A–J) gDNA and DNA methylation measurements for
the corresponding Infinium HumanMethylation450 (450K) data derived from the same ten participants’ gDNA is plotted from ≥1× to ≥10×
rmRRBS reads. Results are stratified by CpG resort context and shown for CpG loci, 200 base pair genomic tiles (200 bp tiles), and 2000 base
pair genomic tiles (2 kb tiles)
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This suggests that rmRRBS is of particular utility for researchers
interested in studying DNAm in human microRNA genes.
Furthermore, epigeneticists interested in SNP genotyping and/or
allele-specific DNAm would benefit from employing rmRRBS in
their research, and the method has the potential for clinical
applications including diagnostics for imprinting disorders and the
detection of diagnostic and prognostic markers, as well as
identification of therapeutic targets.43
It is likely that experimental and analytic approaches to RRBS
derivatives will be further refined in the near future. In order to
decrease variability in coverage and increase both read depth and
overlap between libraries, researchers may select a narrower
range of fragments to enrich for certain CpG contexts, and/or
multiplex fewer samples per lane to return more reads per library.
Experiments that systematically explore fragment selection and
multiplexing would help elucidate these possibilities.
Improvements to genomic tiling and other regional-based
analyses could also augment our ability to detect differences
between samples, such as those associated with diseases or
environmental exposures. Moreover, regional changes in DNAm
associated with a variable interest may have more functional
relevance than locus-specific changes, since gene expression is
not always correlated with DNAm at individual CpG sites. Analysis
pipelines that take advantage of the large number of overlapping
genomic regions between any given two RRBS libraries could yield
more powerful results; perhaps we can even adapt analytic
approaches that have already been developed in other fields.
METHODS
Details available as Supplement.
Fig. 6 Genotype and allele-specific DNA methylation are measured by rmRRBS but not the Infinium BeadChip. A diagram illustrating the
position of the target region in H19 within the 11p15 imprinting region is shown at the top of the figure. The primary sequencing of DNA
nucleotides appears at the bottom, with a G/T single nucleotide polymorphism (SNP) highlighted in a red box in the body of the figure.
Monoallelic DNA methylation for the five CpG loci covered by rmRRBS, as well as overall DNA methylation for the single CpG locus covered by
the Infinium HumanMethylation450 (450K) array, are shown for the six individuals (including one replicate of J) who were heterozygous for
the G/T SNP with blue saturation of heatmap cells indicating DNA methylation levels. Predicted regulatory functions based on Epigenetic
Roadmap chromatin state data is shown above the DNA methylation heatmaps
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Microarray data
Microarray data will be posted to GEO in accordance with MIAME.
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